These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33340254)

  • 1. Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor-targeted chemotherapy of lung cancer.
    Liang X; Liang X
    Kaohsiung J Med Sci; 2021 May; 37(5):411-418. PubMed ID: 33340254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
    Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
    Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
    Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY
    Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells.
    Lin YJ; Liu YS; Yeh HH; Cheng TL; Wang LF
    Int J Nanomedicine; 2012; 7():4169-83. PubMed ID: 22904627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
    Xu W; Lou Y; Chen W; Kang Y
    Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
    Jeong D; Bae BC; Park SJ; Na K
    J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system x
    Yoo SY; Kim HY; Kim DH; Shim WS; Lee SM; Lee DH; Koo JM; Yoo JH; Koh S; Park JC; Yu J; Jeon JS; Baek MJ; Kim DD; Lee JY; Oh SJ; Kim SK; Lee JY; Kang KW
    J Control Release; 2024 Nov; 375():574-588. PubMed ID: 39293529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD44-Targeting Programmable Drug Delivery System for Enhancing and Sensitizing Chemotherapy to Drug-Resistant Cancer.
    Zhang M; Ma Y; Wang Z; Han Z; Gao W; Zhou Q; Gu Y
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5851-5861. PubMed ID: 30648841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment.
    Zhang B; Cheng G; Zheng M; Han J; Wang B; Li M; Chen J; Xiao T; Zhang J; Cai L; Li S; Fan X
    Drug Deliv; 2018 Nov; 25(1):461-471. PubMed ID: 29426237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY; Chung SJ; Cho HJ; Kim DD
    Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A redox-sensitive micelle-like nanoparticle self-assembled from amphiphilic adriamycin-human serum albumin conjugates for tumor targeted therapy.
    Chen L; Chen F; Zhao M; Zhu X; Ke C; Yu J; Yan Z; Zhang F; Sun Y; Chen D; Jiang C; Zhao X; Gao Y; Guo S; Li W
    Biomed Res Int; 2015; 2015():987404. PubMed ID: 26075280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs.
    Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD
    Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
    Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
    Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.
    Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B
    Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy.
    Li M; Sun J; Zhang W; Zhao Y; Zhang S; Zhang S
    Carbohydr Polym; 2021 Jan; 251():117103. PubMed ID: 33142641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
    Gong MQ; Wu C; He XY; Zong JY; Wu JL; Zhuo RX; Cheng SX
    Pharm Res; 2017 Jan; 34(1):148-160. PubMed ID: 27738951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-layered cellulose nanocrystal system for CD44 receptor-positive tumor-targeted anticancer drug delivery.
    Seo JH; Lee SY; Hwang C; Yang M; Lee J; Lee SH; Cho HJ
    Int J Biol Macromol; 2020 Nov; 162():798-809. PubMed ID: 32585268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.